Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?

Clinical Ophthalmology

Volumn 3, Issue 1, 2009, Pages 81-87

  Lee, Susan J ^a   Paranhos, Augusto ^b   Shields, M Bruce ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glaucoma surgery; Intraocular pressure; Mitomycin C; Trabeculectomy

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; TRABECULECTOMY;

EID: 75449105296     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pac Acad Ophthalmol. 1983;9:172-7.
2. Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol. 1990;6:175-82.
3. Kitazawa Y, Kawase K, Matsushita H, et al. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109:1693-8.
4. Skuta GL, Beeson CC, Higginotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99:438-44.
5. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-Fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1995;103:1263-9.
6. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98:317-21.
7. El Sayyad F, Belmekki M, Helal M, et al. Simultaneous subconjunctival and subscleral mitomycin-C application in trabeculectomy. Ophthalmology. 2000;107:298-302.
8. Nuijts RM, Vernimmen RCJ, Webers CA. Mitomycin C primary trabeculectomy in primary glaucoma of white patients. J Glaucoma. 1997;6:293-7.
9. Scott IU, Greenfield DS, Schiffman J, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998;116:286-91.
10. Cohen JS, Novack GD, Li ZL. The role of mitomycin treatment duration and previous intraocular surgery on the success of trabeculectomy surgery. J Glaucoma. 1997;6:3-9.
11. Perkins TW, Gangnon R, Ladd W, et al. Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma. 1998;7:230-6.
12. Shields MB, Scroggs MW, Sloop CM, et al. Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol. 1993;116:673-83.
13. Stone RT, Herndon LW, Allingham RR, et al. Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure. J Glaucoma. 1998;7:39-44.
14. Neelakantan A, Rao BS, Vijaya L, et al. Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg. 1994;25:612-615.
15. Cheung JC, Wright MM, Murali S, et al. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology. 1997;104:143-9.
16. Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol. 1997;115:969-73.
17. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology. 1993;100:1624-8.
18. Sanders SP, Cantor LB, Dobler AA, et al. Mitomycin C in higher risk trabeculectomy: a prospective comparison of 0.2- to 0.4-mg/cc doses. J Glaucoma. 1999;8:193-8.
19. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology. 1992;99:1471-6.
20. Megevand GS, Salmon JF, Scholtz RP, et al. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology. 1995;102:84-90.
21. Kim YY, Sexton RM, Shin DH, et al. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol. 1998;126:755-62.
22. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol. (93);116:314-26.
23. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy: assessment of risk factors for failure. Ophthalmology. 1993;100:928-39.
24. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol. 1992;114:544-53.
25. Fannin LA, Schiffman JC, Budenz DL. Risk factors for hypotony maculopathy. Ophthalmology. 2003;110:1185-91.